The Rare and Undiagnosed Diseases Platform (IBG-RUDiP) was established within the IBG, in line with the mission of the RareBoost project, to drive innovation and research excellence in the field of rare and undiagnosed diseases through a multidisciplinary approach.

RUDiP consists of 15 faculty members and research groups with expertise in different areas of basic, translational, technological and industrial research related to rare and undiagnosed diseases.

Within RUDiP, rare diseases will be studied from different perspectives using the most advanced research techniques. This collaborative effort aims to advance our knowledge of rare diseases and lead to innovative diagnostic methods and treatment options for affected individuals.

RUDiP laboratories specialize in a wide variety of fields, including human genetics, epigenetics, cancer biology, immunology, computational biophysics, molecular biology, bioinformatics, zebrafish models, gene targeting and biobanking.

Platform Members

ÖZBEK LAB

Human genetics

ERKEK LAB

Epigenetics

KALE LAB

Computational biophysics, in silico methods in life sciences

ÖZHAN LAB

Developmental biology, neuroscience, zebrafish disease models

ERDAL LAB

Stem Cell and Organoid Technologies

KALYONCU LAB

Biochemistry, protein engineering, antibody engineering

THORLAB

Adjuvant Innovation and Nanobiotechnology

ATABEY LAB

Cancer Biology and Genetics

OKTAY LAB

Neuro-Genomics

WINGENDER LAB

Immunology

BIOINFORMATICS PLATFORM

Bioinformatics

ZEBRAFISH MODELS LAB

Zebrafish models for disease modeling and drug testing

GENE TARGETING AND TRANSGENIC MODEL PLATFORM

Genetically modified mouse models

IBG-BIOBANK

Rare Disease Biobank

MG LAB

Vaccines and Immunotherapeutics